img

Global Favipiravir Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Favipiravir Market Research Report 2024

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
According to Mr Accuracy reports’s new survey, global Favipiravir market is projected to reach US$ 11 million in 2034, increasing from US$ 342.8 million in 2022, with the CAGR of -22.0% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Favipiravir market research.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Favipiravir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Segment by Type
Brand Drug
Generic Drug

Segment by Application


Influenza Viruses
COVID-19
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Favipiravir report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Favipiravir Market Overview
1.1 Product Overview and Scope of Favipiravir
1.2 Favipiravir Segment by Type
1.2.1 Global Favipiravir Market Value Comparison by Type (2024-2034)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Favipiravir Segment by Application
1.3.1 Global Favipiravir Market Value by Application: (2024-2034)
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Market Size Estimates and Forecasts
1.4.1 Global Favipiravir Revenue 2018-2034
1.4.2 Global Favipiravir Sales 2018-2034
1.4.3 Global Favipiravir Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Favipiravir Market Competition by Manufacturers
2.1 Global Favipiravir Sales Market Share by Manufacturers (2018-2024)
2.2 Global Favipiravir Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Favipiravir Average Price by Manufacturers (2018-2024)
2.4 Global Favipiravir Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Favipiravir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Favipiravir, Product Type & Application
2.7 Favipiravir Market Competitive Situation and Trends
2.7.1 Favipiravir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Favipiravir Players Market Share by Revenue
2.7.3 Global Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Favipiravir Retrospective Market Scenario by Region
3.1 Global Favipiravir Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Favipiravir Global Favipiravir Sales by Region: 2018-2034
3.2.1 Global Favipiravir Sales by Region: 2018-2024
3.2.2 Global Favipiravir Sales by Region: 2024-2034
3.3 Global Favipiravir Global Favipiravir Revenue by Region: 2018-2034
3.3.1 Global Favipiravir Revenue by Region: 2018-2024
3.3.2 Global Favipiravir Revenue by Region: 2024-2034
3.4 North America Favipiravir Market Facts & Figures by Country
3.4.1 North America Favipiravir Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Favipiravir Sales by Country (2018-2034)
3.4.3 North America Favipiravir Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Favipiravir Market Facts & Figures by Country
3.5.1 Europe Favipiravir Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Favipiravir Sales by Country (2018-2034)
3.5.3 Europe Favipiravir Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Favipiravir Market Facts & Figures by Country
3.6.1 Asia Pacific Favipiravir Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Favipiravir Sales by Country (2018-2034)
3.6.3 Asia Pacific Favipiravir Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Favipiravir Market Facts & Figures by Country
3.7.1 Latin America Favipiravir Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Favipiravir Sales by Country (2018-2034)
3.7.3 Latin America Favipiravir Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Favipiravir Market Facts & Figures by Country
3.8.1 Middle East and Africa Favipiravir Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Favipiravir Sales by Country (2018-2034)
3.8.3 Middle East and Africa Favipiravir Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Favipiravir Sales by Type (2018-2034)
4.1.1 Global Favipiravir Sales by Type (2018-2024)
4.1.2 Global Favipiravir Sales by Type (2024-2034)
4.1.3 Global Favipiravir Sales Market Share by Type (2018-2034)
4.2 Global Favipiravir Revenue by Type (2018-2034)
4.2.1 Global Favipiravir Revenue by Type (2018-2024)
4.2.2 Global Favipiravir Revenue by Type (2024-2034)
4.2.3 Global Favipiravir Revenue Market Share by Type (2018-2034)
4.3 Global Favipiravir Price by Type (2018-2034)
5 Segment by Application
5.1 Global Favipiravir Sales by Application (2018-2034)
5.1.1 Global Favipiravir Sales by Application (2018-2024)
5.1.2 Global Favipiravir Sales by Application (2024-2034)
5.1.3 Global Favipiravir Sales Market Share by Application (2018-2034)
5.2 Global Favipiravir Revenue by Application (2018-2034)
5.2.1 Global Favipiravir Revenue by Application (2018-2024)
5.2.2 Global Favipiravir Revenue by Application (2024-2034)
5.2.3 Global Favipiravir Revenue Market Share by Application (2018-2034)
5.3 Global Favipiravir Price by Application (2018-2034)
6 Key Companies Profiled
6.1 ChemRar Group
6.1.1 ChemRar Group Corporation Information
6.1.2 ChemRar Group Description and Business Overview
6.1.3 ChemRar Group Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.1.4 ChemRar Group Favipiravir Product Portfolio
6.1.5 ChemRar Group Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Corporation Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Glenmark Favipiravir Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Corporation Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Fujifilm Favipiravir Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Dr. Reddy
6.4.1 Dr. Reddy Corporation Information
6.4.2 Dr. Reddy Description and Business Overview
6.4.3 Dr. Reddy Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Dr. Reddy Favipiravir Product Portfolio
6.4.5 Dr. Reddy Recent Developments/Updates
6.5 R-Pharma
6.5.1 R-Pharma Corporation Information
6.5.2 R-Pharma Description and Business Overview
6.5.3 R-Pharma Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.5.4 R-Pharma Favipiravir Product Portfolio
6.5.5 R-Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Cipla Favipiravir Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Lupin Favipiravir Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Corporation Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sun Pharma Favipiravir Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hisun Pharm
6.9.1 Hisun Pharm Corporation Information
6.9.2 Hisun Pharm Description and Business Overview
6.9.3 Hisun Pharm Favipiravir Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hisun Pharm Favipiravir Product Portfolio
6.9.5 Hisun Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Favipiravir Industry Chain Analysis
7.2 Favipiravir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Favipiravir Production Mode & Process
7.4 Favipiravir Sales and Marketing
7.4.1 Favipiravir Sales Channels
7.4.2 Favipiravir Distributors
7.5 Favipiravir Customers
8 Favipiravir Market Dynamics
8.1 Favipiravir Industry Trends
8.2 Favipiravir Market Drivers
8.3 Favipiravir Market Challenges
8.4 Favipiravir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Favipiravir Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Favipiravir Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Favipiravir Market Competitive Situation by Manufacturers in 2022
Table 4. Global Favipiravir Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Favipiravir Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Favipiravir Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Favipiravir Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Favipiravir Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Favipiravir, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Favipiravir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Favipiravir, Product Type & Application
Table 12. Global Key Manufacturers of Favipiravir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Favipiravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Favipiravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Favipiravir Sales by Region (2018-2024) & (K Units)
Table 18. Global Favipiravir Sales Market Share by Region (2018-2024)
Table 19. Global Favipiravir Sales by Region (2024-2034) & (K Units)
Table 20. Global Favipiravir Sales Market Share by Region (2024-2034)
Table 21. Global Favipiravir Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Favipiravir Revenue Market Share by Region (2018-2024)
Table 23. Global Favipiravir Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Favipiravir Revenue Market Share by Region (2024-2034)
Table 25. North America Favipiravir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Favipiravir Sales by Country (2018-2024) & (K Units)
Table 27. North America Favipiravir Sales by Country (2024-2034) & (K Units)
Table 28. North America Favipiravir Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Favipiravir Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Favipiravir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Favipiravir Sales by Country (2018-2024) & (K Units)
Table 32. Europe Favipiravir Sales by Country (2024-2034) & (K Units)
Table 33. Europe Favipiravir Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Favipiravir Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Favipiravir Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Favipiravir Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Favipiravir Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Favipiravir Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Favipiravir Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Favipiravir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Favipiravir Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Favipiravir Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Favipiravir Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Favipiravir Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Favipiravir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Favipiravir Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Favipiravir Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Favipiravir Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Favipiravir Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Favipiravir Sales (K Units) by Type (2018-2024)
Table 51. Global Favipiravir Sales (K Units) by Type (2024-2034)
Table 52. Global Favipiravir Sales Market Share by Type (2018-2024)
Table 53. Global Favipiravir Sales Market Share by Type (2024-2034)
Table 54. Global Favipiravir Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Favipiravir Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Favipiravir Revenue Market Share by Type (2018-2024)
Table 57. Global Favipiravir Revenue Market Share by Type (2024-2034)
Table 58. Global Favipiravir Price (US$/Unit) by Type (2018-2024)
Table 59. Global Favipiravir Price (US$/Unit) by Type (2024-2034)
Table 60. Global Favipiravir Sales (K Units) by Application (2018-2024)
Table 61. Global Favipiravir Sales (K Units) by Application (2024-2034)
Table 62. Global Favipiravir Sales Market Share by Application (2018-2024)
Table 63. Global Favipiravir Sales Market Share by Application (2024-2034)
Table 64. Global Favipiravir Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Favipiravir Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Favipiravir Revenue Market Share by Application (2018-2024)
Table 67. Global Favipiravir Revenue Market Share by Application (2024-2034)
Table 68. Global Favipiravir Price (US$/Unit) by Application (2018-2024)
Table 69. Global Favipiravir Price (US$/Unit) by Application (2024-2034)
Table 70. ChemRar Group Corporation Information
Table 71. ChemRar Group Description and Business Overview
Table 72. ChemRar Group Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. ChemRar Group Favipiravir Product
Table 74. ChemRar Group Recent Developments/Updates
Table 75. Glenmark Corporation Information
Table 76. Glenmark Description and Business Overview
Table 77. Glenmark Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Glenmark Favipiravir Product
Table 79. Glenmark Recent Developments/Updates
Table 80. Fujifilm Corporation Information
Table 81. Fujifilm Description and Business Overview
Table 82. Fujifilm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Fujifilm Favipiravir Product
Table 84. Fujifilm Recent Developments/Updates
Table 85. Dr. Reddy Corporation Information
Table 86. Dr. Reddy Description and Business Overview
Table 87. Dr. Reddy Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Dr. Reddy Favipiravir Product
Table 89. Dr. Reddy Recent Developments/Updates
Table 90. R-Pharma Corporation Information
Table 91. R-Pharma Description and Business Overview
Table 92. R-Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. R-Pharma Favipiravir Product
Table 94. R-Pharma Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Cipla Favipiravir Product
Table 99. Cipla Recent Developments/Updates
Table 100. Lupin Corporation Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Lupin Favipiravir Product
Table 104. Lupin Recent Developments/Updates
Table 105. Sun Pharma Corporation Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sun Pharma Favipiravir Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Hisun Pharm Corporation Information
Table 111. Hisun Pharm Description and Business Overview
Table 112. Hisun Pharm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Hisun Pharm Favipiravir Product
Table 114. Hisun Pharm Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Favipiravir Distributors List
Table 118. Favipiravir Customers List
Table 119. Favipiravir Market Trends
Table 120. Favipiravir Market Drivers
Table 121. Favipiravir Market Challenges
Table 122. Favipiravir Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Favipiravir
Figure 2. Global Favipiravir Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Favipiravir Market Share by Type in 2022 & 2034
Figure 4. Brand Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Favipiravir Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Favipiravir Market Share by Application in 2022 & 2034
Figure 8. Influenza Viruses
Figure 9. COVID-19
Figure 10. Others
Figure 11. Global Favipiravir Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Favipiravir Market Size (2018-2034) & (US$ Million)
Figure 13. Global Favipiravir Sales (2018-2034) & (K Units)
Figure 14. Global Favipiravir Average Price (US$/Unit) & (2018-2034)
Figure 15. Favipiravir Report Years Considered
Figure 16. Favipiravir Sales Share by Manufacturers in 2022
Figure 17. Global Favipiravir Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Favipiravir Players: Market Share by Revenue in 2022
Figure 19. Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Favipiravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Favipiravir Sales Market Share by Country (2018-2034)
Figure 22. North America Favipiravir Revenue Market Share by Country (2018-2034)
Figure 23. United States Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Favipiravir Sales Market Share by Country (2018-2034)
Figure 26. Europe Favipiravir Revenue Market Share by Country (2018-2034)
Figure 27. Germany Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Favipiravir Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Favipiravir Revenue Market Share by Region (2018-2034)
Figure 34. China Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Favipiravir Sales Market Share by Country (2018-2034)
Figure 44. Latin America Favipiravir Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Favipiravir Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Favipiravir Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Favipiravir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Favipiravir by Type (2018-2034)
Figure 54. Global Revenue Market Share of Favipiravir by Type (2018-2034)
Figure 55. Global Favipiravir Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Favipiravir by Application (2018-2034)
Figure 57. Global Revenue Market Share of Favipiravir by Application (2018-2034)
Figure 58. Global Favipiravir Price (US$/Unit) by Application (2018-2034)
Figure 59. Favipiravir Value Chain
Figure 60. Favipiravir Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed